Is the era of chemotherapy over in CLL?
John Gribben et al.
Using ponatinib to treat highly resistant chronic myeloid leukemia, results from a Phase I trial
Michael J. Mauro
The CLL patient: devising a management plan
BOPA 2017: What are the hot topics?
Results of KEYNOTE-023 and pembrolizumab plus pomalidomide trials for multiple myeloma
Jesús San Miguel